ATE430573T1 - Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen - Google Patents

Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen

Info

Publication number
ATE430573T1
ATE430573T1 AT00907851T AT00907851T ATE430573T1 AT E430573 T1 ATE430573 T1 AT E430573T1 AT 00907851 T AT00907851 T AT 00907851T AT 00907851 T AT00907851 T AT 00907851T AT E430573 T1 ATE430573 T1 AT E430573T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaucetic
acidificants
burns
source
Prior art date
Application number
AT00907851T
Other languages
English (en)
Inventor
Arthur Tudor Tucker
Nigel Benjamin
Original Assignee
Queen Mary & Westfield College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary & Westfield College filed Critical Queen Mary & Westfield College
Application granted granted Critical
Publication of ATE430573T1 publication Critical patent/ATE430573T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AT00907851T 1999-03-09 2000-03-09 Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen ATE430573T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9905425.6A GB9905425D0 (en) 1999-03-09 1999-03-09 Pharmaceutical composition
PCT/GB2000/000853 WO2000053193A1 (en) 1999-03-09 2000-03-09 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia

Publications (1)

Publication Number Publication Date
ATE430573T1 true ATE430573T1 (de) 2009-05-15

Family

ID=10849290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00907851T ATE430573T1 (de) 1999-03-09 2000-03-09 Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen

Country Status (11)

Country Link
US (3) US20020090401A1 (de)
EP (1) EP1161248B1 (de)
JP (1) JP5084985B2 (de)
AT (1) ATE430573T1 (de)
AU (1) AU2931500A (de)
DE (1) DE60042153D1 (de)
DK (1) DK1161248T3 (de)
ES (1) ES2326729T3 (de)
GB (1) GB9905425D0 (de)
PT (1) PT1161248E (de)
WO (1) WO2000053193A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180379A1 (en) 2000-07-27 2003-09-25 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US6780849B2 (en) 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US7040313B2 (en) * 2001-09-05 2006-05-09 Cyterra Corporation Method and apparatus for nitric oxide generation
AU2004257693B8 (en) 2003-07-09 2009-08-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
EP1789119B1 (de) 2004-08-18 2017-10-18 Geno LLC Umwandlung von stickstoffdioxid (no2) zu stickoxid (no)
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
ES2326387T3 (es) * 2005-03-24 2009-10-08 Nolabs Ab Tratamiento cosmetico con oxido nitrico, dispositivo para llevar a cabo dicho tratamiento y procedimiento de fabricacion del mismo.
WO2006128121A2 (en) 2005-05-27 2006-11-30 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
GB0607402D0 (en) 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
US20110189309A1 (en) * 2007-07-12 2011-08-04 Whipbird Pain Relief Pty Ltd Acn 132 827 411 Topical medicament
US9278157B2 (en) 2007-08-09 2016-03-08 Insense Limited Nitric oxide-generating skin dressings
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US20090130233A1 (en) * 2007-10-24 2009-05-21 Baker Christopher G Two part lotion
US10080823B2 (en) 2007-10-30 2018-09-25 Gearbox Llc Substrates for nitric oxide releasing devices
US8980332B2 (en) 2007-10-30 2015-03-17 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
US8877508B2 (en) 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
JP5795165B2 (ja) 2007-11-15 2015-10-14 ルイジアナ ステイト ユニヴァーシティー 慢性虚血における亜硝酸塩の使用
WO2009086470A2 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
US7914743B2 (en) 2008-01-28 2011-03-29 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
EP2300604A4 (de) * 2008-06-24 2011-07-27 Micropharma Ltd Stickoxidzusammensetzungen sowie vorrichtungen und verfahren für kosmese
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
US20120237617A1 (en) 2009-06-18 2012-09-20 Theravasc Inc. Use of nitrite salts in treating tissue damage
AU2010263098B2 (en) 2009-06-22 2016-01-07 VERO Biotech LLC. Nitric oxide therapies
ES2958410T3 (es) 2009-08-21 2024-02-08 Novan Inc Geles tópicos
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
ES2633618T3 (es) 2009-10-14 2017-09-22 Theravasc Inc. Formulaciones farmacéuticas de nitrito y sus usos
JP5995724B2 (ja) * 2009-11-20 2016-09-21 ゲノ エルエルシー 一酸化窒素送達システム
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
KR20160120785A (ko) * 2011-08-17 2016-10-18 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 경구 전달 시스템을 통해 생리학적 및 치료학적 수준의 일산화질소를 생산하는 방법
AU2014218916A1 (en) 2013-02-20 2015-09-03 Theravasc Inc. Pharmaceutical formulations of nitrite and uses thereof
GB201309091D0 (en) * 2013-05-20 2013-07-03 Edixomed Ltd Dressing system
GB201309092D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Transdermal delivery system
GB201420761D0 (en) 2014-11-21 2015-01-07 Edixomed Ltd And First Water Ltd Dressing system
TWI562038B (en) * 2015-07-08 2016-12-11 Wistron Corp Method of detecting touch position and touch apparatus thereof
GB201520990D0 (en) 2015-11-27 2016-01-13 Edixomed Ltd Dressing system
WO2020227367A1 (en) * 2019-05-06 2020-11-12 Pneuma Nitric Oxide, Llc Nitric oxide compositions and topical uses thereof
JP7686578B2 (ja) 2019-06-04 2025-06-02 サーティー レスピラトリー リミテッド 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用
JP2023510661A (ja) * 2019-06-04 2023-03-15 サーティー ホールディングス リミテッド 窒素酸化物を生成するための方法及び組成物、並びにそれらの使用
BR112022021454A2 (pt) * 2020-04-23 2023-01-31 Thirty Respiratory Ltd Óxido nítrico ou composições liberadoras de óxido nítrico para uso no tratamento de sars-cov e sars-cov-2
US20230172973A1 (en) 2020-04-23 2023-06-08 Thirty Respiratory Limited Methods and compositions for treating and combatting tuberculosis
WO2024220093A2 (en) * 2023-04-20 2024-10-24 LifeActive, Inc. Transdermal delivery formulations and methods for the manufacture thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH629100A5 (de) * 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
EP0644766B1 (de) * 1992-06-08 1999-03-17 Pitmy International N.V. Distickstoffmonoxide enthaldendes dermatologisches präparat
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
DE69532921T2 (de) * 1994-02-21 2005-04-14 Aberdeen University, Aberdeen Angesäuertes nitrit zur verwendung als antimikrobielles mittel
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
JP3002772B2 (ja) * 1996-05-15 2000-01-24 マルホ株式会社 貼付剤及びその製造法
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US7404990B2 (en) * 2002-11-14 2008-07-29 Air Products And Chemicals, Inc. Non-thermal process for forming porous low dielectric constant films
US7056840B2 (en) * 2003-09-30 2006-06-06 International Business Machines Corp. Direct photo-patterning of nanoporous organosilicates, and method of use

Also Published As

Publication number Publication date
JP5084985B2 (ja) 2012-11-28
DK1161248T3 (da) 2009-08-31
DE60042153D1 (de) 2009-06-18
ES2326729T3 (es) 2009-10-19
EP1161248A1 (de) 2001-12-12
AU2931500A (en) 2000-09-28
JP2002538210A (ja) 2002-11-12
PT1161248E (pt) 2009-08-05
GB9905425D0 (en) 1999-05-05
US20150004258A1 (en) 2015-01-01
US20080226751A1 (en) 2008-09-18
EP1161248B1 (de) 2009-05-06
US20020090401A1 (en) 2002-07-11
WO2000053193A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
ATE430573T1 (de) Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen
ES2275716T3 (es) Composicion farmaceutica de liberacion transdermica.
MXPA02002895A (es) Tratamiento topico de infecciones por estreptococcus.
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ATE264685T1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
MXPA02009904A (es) Derivados de apomorfina y metodos para su uso.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
NZ513096A (en) Compositions for treating inflammatory response
DE69034070D1 (de) Racemisches Huperzin A
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
BR0111989A (pt) Peptìdeos, composições e processos para o tratamento de burkholderia cepacia
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
DK227090A (da) Organisk guldkompleks til topisk anvendelse
ATE232390T1 (de) Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs
UY26426A1 (es) Nuevos compuestos
ATE390124T1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
ATE310539T1 (de) Artikel zur wundbehandlung
ATE286890T1 (de) Biologisch wirksame, analoge verbindungen von discodermoliden
SE0000303D0 (sv) Novel compounds
ATE405276T1 (de) Pharmazeutische gel-zusammensetzung
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
SE0004780D0 (sv) Novel compunds
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1161248

Country of ref document: EP